These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Myelodysplastic syndromes: preleukemic syndromes].
    Author: Tassin F, Hermanne JP, Schaaf-Lafontaine N, Herens C, Thiry A, Paulus JM, Boniver J, Fillet G.
    Journal: Rev Med Liege; 1998 Jun; 53(6):357-62. PubMed ID: 9713217.
    Abstract:
    The myelodysplastic syndromes (MDS) are a heterogeneous group of disorders characterized by peripheral blood cytopenias with a hypercellular bone marrow exhibiting dyspoiesis. The predominant in elderly patients are associated with a high risk of progression to acute myelogenous leukemia. The etiology of MDS is unknown in most cases. About 10% of MDSs are secondary. MDS are classified by the French American British (FAB) classification into five subgroups. The incidence of the disorders is difficult to estimate but it seems to be increasing. Clonal cytogenetic aberrations are found in 30 to 50% of de novo MDS. The only currative treatment for MDS is allogeneic bone marrow transplantation.
    [Abstract] [Full Text] [Related] [New Search]